The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Microalbuminuria and the Risk for Early Progressive Renal Function Decline in Type 1 Diabetes
Abstract
This study aimed to establish the time of initiation and the determinants of renal function decline in type 1 diabetes. Until now, such decline has been assumed to be a late-occurring event associated with proteinuria. A total of 267 patients with normoalbuminuria and 301 patients with microalbuminuria were followed for 8 to 12 yr. Linear trends (slopes) in GFR were estimated by serial measurement of serum cystatin C. Cases of early renal function decline were defined by loss in cystatin C GFR that exceeded -3.3%/yr, a threshold that corresponds to the 2.5th percentile of the distribution of GFR slopes in an independent nondiabetic normotensive population. Cases of early renal function decline occurred in 9% (mean slope -4.4; range -5.9 to -3.3%/yr) of the normoalbuminuria group and 31% (mean slope -7.1; range -23.8 to -3.3%/yr) of the microalbuminuria group (P < 0.001). Risk for early renal function decline depended on whether microalbuminuria regressed, remained stable, or progressed, rising from 16 to 32 and 68%, respectively (P < 0.001). In multivariate analysis, risk for decline was higher after age 35 yr or when glycosylated hemoglobin exceeded 9% but did not vary with diabetes duration, smoking, BP, or angiotensin-converting enzyme inhibitor treatment. Contrary to the existing paradigm of diabetic nephropathy, progressive renal function decline in type 1 diabetes is an early event that occurs in a large proportion of patients with microalbuminuria. Together with testing for microalbuminuria, clinical protocols using cystatin C to diagnose early renal function decline and track response to therapeutic interventions should be developed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011) · Wiley Series in Probability and Statistics · doi:10.1002/9781119513469 · Cited by 4,639
MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS
Viberti, G. C., Jarrett, R. J., Mahmud, U., Hill, R. D., Argyropoulos, A., & Keen, H. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92450-3 · Cited by 1,663
Longitudinal Studies on the Rate of Decline in Renal Function with Age
Lindeman, R. D., Tobin, J., & Shock, N. W. (1985) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1985.tb07117.x · Cited by 1,578
Predicting Diabetic Nephropathy in Insulin-Dependent Patients
Mogensen, C. E., & Christensen, C. K. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407123110204 · Cited by 1,569
Cystatin C and the Risk of Death and Cardiovascular Events among Elderly Persons
Shlipak, M. G., Sarnak, M. J., Katz, R., Fried, L. F., Seliger, S. L., Newman, A. B., Siscovick, D. S., & Stehman-Breen, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043161 · Cited by 1,249
Structural-functional relationships in diabetic nephropathy.
Mauer, S. M., Steffes, M. W., Ellis, E. N., Sutherland, D. E., Brown, D. M., & Goetz, F. C. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111523 · Cited by 1,209
Regression of Microalbuminuria in Type 1 Diabetes
Perkins, B. A., Ficociello, L. H., Silva, K. H., Finkelstein, D. M., Warram, J. H., & Krolewski, A. S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021835 · Cited by 801
Self-citationNewman, D. J., Thakkar, H., Edwards, R. G., Wilkie, M., White, T., Grubb, A. O., & Price, C. P. (1995) · Kidney International · doi:10.1038/ki.1995.40 · Cited by 650
Parving, H.-H., Oxenbøll, B., Svendsen, P. A., Christiansen, J. S., & Andersen, A. R. (1982) · Acta Endocrinologica · doi:10.1530/acta.0.1000550 · Cited by 572
Krolewski, A. S., Laffel, L. M. B., Krolewski, M., Quinn, M., & Warram, J. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505113321902 · Cited by 452
Self-citationHovind, P., Tarnow, L., Rossing, P., Graae, M., Torp, I., Binder, C., & Parving, H.-H. (2004) · BMJ · doi:10.1136/bmj.38070.450891.fe · Cited by 432
Zeller, K., Whittaker, E., Sullivan, L., Raskin, P., & Jacobson, H. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101103240202 · Cited by 409
Cystatin C—A New Marker of Glomerular Filtration Rate in Children Independent of Age and Height
Bökenkamp, A., Domanetzki, M., Zinck, R., Schumann, G., Byrd, D., & Brodehl, J. (1998) · Pediatrics · doi:10.1542/peds.101.5.875 · Cited by 392
Serum Cystatin C Concentration as a Marker of Renal Dysfunction in the Elderly
FLISER, D., & RITZ, E. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.20591 · Cited by 391
Progression of diabetic nephropathy
Hovind, P., Rossing, P., Tarnow, L., Smidt, U. M., & Parving, H.-H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002702.x · Cited by 383
Mogensen, C. E. (1976) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365517609055274 · Cited by 375
Perkins, B. A., Nelson, R. G., Ostrander, B. E. P., Blouch, K. L., Krolewski, A. S., Myers, B. D., & Warram, J. H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100854 · Cited by 323
Self-citationThe Early Natural History of Nephropathy in Type 1 Diabetes
Drummond, K., Mauer, M., & for the International Diabetic Nephropathy Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.5.1580 · Cited by 303
Low Glomerular Filtration Rate in Normoalbuminuric Type 1 Diabetic Patients
Caramori, M. L., Fioretto, P., & Mauer, M. (2003) · Diabetes · doi:10.2337/diabetes.52.4.1036 · Cited by 301
Glomerular Lesions and Urinary Albumin Excretion in Type I Diabetes without Overt Proteinuria
Chavers, B. M., Bilous, R. W., Ellis, E. N., Steffes, M. W., & Mauer, S. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904133201503 · Cited by 283
Wiseman, M. J., Saunders, A. J., Keen, H., & Viberti, G. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503073121004 · Cited by 266
Vinge, E., Lindergård, B., Nilsson–Ehle, P., & Grubb, A. (1999) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519950185076 · Cited by 265
Feldt-Rasmussen, B., Mathiesen, E. R., Jensen, T., Lauritzen, T., & Deckert, T. (1991) · Diabetologia · doi:10.1007/bf00418270 · Cited by 222
Parving, H.-H., Smidt, U. M., Friisberg, B., Bonnevie-Nielsen, V., & Andersen, A. R. (1981) · Diabetologia · doi:10.1007/bf00253407 · Cited by 217
Oberg, A. L., & Mahoney, D. W. (2007) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-530-5_11 · Cited by 207
Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency
Hsu, C.-Y., Chertow, G. M., & Curhan, G. C. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00299.x · Cited by 196
The Early Natural History of Nephropathy in Type 1 Diabetes
Steinke, J. M., Sinaiko, A. R., Kramer, M. S., Suissa, S., Chavers, B. M., Mauer, M., & for the International Diabetic Nephropathy Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.7.2164 · Cited by 190
Monitoring glomerular function in diabetic nephropathy
Viberti, G. C., Bilous, R. W., Mackintosh, D., & Keen, H. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90624-1 · Cited by 184
Serum cystatin C as a marker of glomerular filtration rate
Madero, M., Sarnak, M. J., & Stevens, L. A. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000247505.71915.05 · Cited by 167
Magnitude of end-stage renal disease in IDDM: A 35 year follow-up study
Krolewski, M., Eggers, P. W., & Warram, J. H. (1996) · Kidney International · doi:10.1038/ki.1996.527 · Cited by 160
Self-citationTan, G. D., Lewis, A. V., James, T. J., Altmann, P., Taylor, R. P., & Lévy, J. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2004 · Cited by 154
Amin, R., Turner, C., Aken, S. V., Bahu, T. K., Watts, A., Lindsell, D. R., Dalton, R. N., & Dunger, D. B. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00590.x · Cited by 150
Giorgino, F., Laviola, L., Perin, P. C., Solnica, B., Fuller, J., & Chaturvedi, N. (2004) · Diabetologia · doi:10.1007/s00125-004-1413-8 · Cited by 148
Scott, L. J., Warram, J. H., Ficociello, L., Laffel, L. M., RYAN, L. M., & Królewski, A. S. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2842 · Cited by 138
Self-citationChronic Kidney Disease in the Elderly — How to Assess Risk
Stevens, L. A., & Levey, A. S. (2005) · New England Journal of Medicine · doi:10.1056/nejme058035 · Cited by 137
Lane, P. H., Steffes, M. W., & Mauer, S. M. (1992) · Diabetes · doi:10.2337/diab.41.5.581 · Cited by 125
Dahlquist, G. G., Stattin, E., & Rudberg, S. L. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.7.1382 · Cited by 105
Warram, J. H., Scott, L. J., Ficociello, L., Wantman, M., Cohen, S., Laffel, L. M., RYAN, L. M., & Krolewski, A. S. (2000) · Diabetes · doi:10.2337/diabetes.49.1.94 · Cited by 97
Self-citationEnhancing the Predictive Value of Urinary Albumin for Diabetic Nephropathy
Caramori, M. L., Fioretto, P., & Mauer, M. S. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101075 · Cited by 96
Albuminuria and Vascular Damage — The Vicious Twins
Ritz, E. (2003) · New England Journal of Medicine · doi:10.1056/nejme030066 · Cited by 82
Bangstad, H. ‐., Østerby, R., Rudberg, S. L., Hartmann, A., Brabrand, K., & Hanssen, K. F. (2002) · Diabetologia · doi:10.1007/s00125-001-0744-y · Cited by 64
Commentary: Clinical diagnostic use of cystatin C
Massey, D. H. (2004) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.10098 · Cited by 60
Effects of Duration and Age at Onset of Type 1 Diabetes on Preclinical Manifestations of Nephropathy
Drummond, K. N., Kramer, M. S., Suissa, S., Lévy‐Marchal, C., Dell’Aniello, S., Sinaiko, A. R., Mauer, M. S., & for the *International Diabetic Nephropathy Study Group (2003) · Diabetes · doi:10.2337/diabetes.52.7.1818 · Cited by 59
Glomerular Hyperfiltration in Human Diabetes
Mogensen, C. E. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.770 · Cited by 53
Prevention of Loss of Renal Function Over Time in Patients with Diabetic Nephropathy
Barnett, A. H. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.013 · Cited by 52
Nair, K. S., Pabico, R. C., Truglia, J. A., et al. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.711 · Cited by 19
Cystatin C and the Risk of Death
Berghout, A., Wulkan, R. W., & den Hollander, J. G. (2005) · New England Journal of Medicine · doi:10.1056/nejmc051667 · Cited by 18
Cited by
Thomas, M. C., Brownlee, M., Susztak, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P., Groop, P.-H., & Cooper, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.18 · Cited by 1,230
Renal and retinal effects of enalapril and losartan in type 1 diabetes
Mauer, M., Zinman, B., Gardiner, R., Suissa, S., Sinaiko, A., Strand, T., Drummond, K., Donnelly, S., Goodyer, P., Gubler, M. C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808400 · Cited by 791
Transcriptome Analysis of Human Diabetic Kidney Disease
Woroniecka, K. I., Park, A. S. D., Mohtat, D., Thomas, D. B., Pullman, J. M., & Susztak, K. (2011) · Diabetes · doi:10.2337/db10-1181 · Cited by 642
Diabetic nephropathy – complications and treatment
Lim, A. (2014) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s40172 · Cited by 583
Circulating microRNAs as novel biomarkers for diabetes mellitus
Guay, C., & Regazzi, R. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.86 · Cited by 563
Metadata
- Authors
- Perkins, B. A., Ficociello, L. H., Ostrander, B. E., Silva, K. H., Weinberg, J., Warram, J. H., & Krolewski, A. S.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2007-04
- Volume
- 18
- Issue
- 4
- Pages
- 1353-1361
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2112894886
- Cited by
- 370
- References
- 47
- FWCI
- 14.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.